IL17A and myeloid sarcoma: The expressions of TLR2 and TLR4 on Th17 (IL-17+CD4+ T cells)/Tc-17 (IL-17+CD8+ T cells) were significantly upregulated in MS with major depressive disorder (MDD) compared with MS (46).